Related Experiment Videos
Antithrombotic- and anticoagulation regimens in OPCAB surgery. A Nordic survey
Katrine H Hansen1, Pia Hughes, Daniel A Steinbrüchel
1Department of Cardiothoracic Surgery, H:S Rigshospitalet, Copenhagen University Hospital, Denmark. katrineha3@m1.stud.ku.dk
Insights
Practices for antiplatelet and heparin therapy in Off-Pump Coronary Artery Bypass (OPCAB) surgery vary widely across Nordic countries. Standardized protocols for antiplatelet and heparin use in OPCAB surgery are not yet established.
Area of Science:
- Cardiothoracic Surgery
- Cardiovascular Research
- Anesthesiology
Background:
- Off-Pump Coronary Artery Bypass (OPCAB) surgery is performed in the Nordic countries.
- Current practices for perioperative antiplatelet and heparin therapy in OPCAB surgery are not well-defined.
Purpose of the Study:
- To determine current practices for antiplatelet and heparin therapy in OPCAB surgery.
- To identify variations in therapeutic approaches across Nordic countries.
Main Methods:
- A 100% response rate postal survey was conducted.
- The survey targeted all 26 Cardiothoracic Surgery departments in Norway, Sweden, Iceland, Finland, and Denmark.
- Data on antiplatelet and heparin therapy in OPCAB procedures were collected.
Main Results:
- 48% of departments used preoperative antiplatelet therapy; 96% used postoperative therapy.
- Postoperative therapy showed a trend towards aspirin and low molecular weight heparin.
- Heparin anticoagulation and protamine reversal practices varied significantly.
- 80% of respondents reported registering postoperative complications.
Conclusions:
- There is no uniform practice for antiplatelet and heparin therapy in OPCAB surgery in the Nordic countries.
- Dose regimens for these therapies are highly variable.
- Standardized protocols for perioperative management in OPCAB surgery have not been developed.
Objectives:
The aim of the survey was to determine current practices for antiplatelet- and heparin therapy in OPCAB surgery in the Nordic countries.
Design:
A postal survey questionnaire was sent to all 26 departments of Cardiothoracic Surgery in Norway, Sweden, Iceland, Finland, and Denmark.
Results:
The overall response rate was 100%. The respondents performed between 130 and 1000 CABG procedures per year. Between 0.3% and 42.0% of these procedures were performed as OPCAB. Preoperative antiplatelet therapy was administered by 48%, while 96% routinely administer postoperative antiplatelet therapy. In the postoperative antiplatelet therapy there was a trend toward a combination of aspirin and low molecular weight heparin. Perioperative anticoagulation practices with heparin varied among departments as well as reversal with protamine. Eighty percent of the respondents register postoperative complications.
Conclusion:
In the Nordic countries there is no uniform practice regarding antiplatelet therapy pre- and postoperatively as well as heparin therapy perioperatively. Dose regimens are highly variable and standard protocols have not yet been developed.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management
Aneurysm IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins